Fiber Supplements for High Cholesterol (Dyslipidemia)

Fiber supplements do lower LDL cholesterol, and the evidence is deep. The largest analysis pooled 181 randomized trials in 14,505 adults and found LDL fell by 8.28 mg/dL and apolipoprotein B by 44.99 mg/L on soluble fiber (Ghavami 2023). Each extra 5 g a day was linked to a 5.57 mg/dL lower LDL.

The effect is modest. Eight points of LDL is meaningful for a population but small for one person with a high reading, and the trials measured blood lipids, not heart attacks or strokes. Fiber fits as an add-on to a low-saturated-fat diet and, where prescribed, to a statin. Psyllium is the best-studied type; see the psyllium husk page and beta-glucans for single-ingredient detail.

In a randomized, double-blind crossover trial, 20 men with moderate hypercholesterolemia (LDL about 184 mg/dL) took 15 g a day of psyllium or a cellulose placebo for 40 days each. Psyllium lowered LDL to 169 mg/dL versus 179 mg/dL on placebo, reduced relative cholesterol absorption, and increased the turnover of the bile acids chenodeoxycholic acid and cholic acid.

Bile acid synthesis rose in the men whose LDL fell by more than 10%, and the authors concluded psyllium lowers LDL primarily by stimulating bile acid synthesis (Everson 1992). The liver makes bile acids from cholesterol, so pulling more cholesterol into bile acids draws it out of the blood.

That trial was small and short, and it studied psyllium only. The reviews pooled here covered viscous soluble fibers: psyllium, konjac glucomannan and oat beta-glucan. They do not show that every fiber lowers cholesterol, and none of them assessed insoluble fibers such as wheat bran.

A better lipid panel is also a stand-in for the outcome people care about. The Plantago review estimated the LDL fall corresponds to about a 7% lower cardiovascular event risk, but that is the authors' estimate from the lipid change, not a result observed in a trial (Zhu 2024).

Psyllium doses in trials ran from 3.0 to 20.4 g a day, and cholesterol lowering rose with dose and with time on treatment (Wei 2009). The LDL meta-analysis pooled a median of about 10.2 g a day (Jovanovski 2018). In the statin add-on trial, patients took 15 g a day.

Other forms are lower-dose: about 3 g a day of konjac glucomannan (Ho 2017) and 3 g or more a day of oat beta-glucan, with no clear extra effect up to 12.4 g (Whitehead 2014). The FDA heart-health claim uses 7 g a day of soluble fiber from psyllium husk or 3 g a day of beta-glucan, within a diet low in saturated fat and cholesterol. The abstracts I read do not report how doses were timed or titrated.

Ghavami 2023 pooled 181 randomized trials (220 treatment arms, 14,505 participants) of soluble fiber supplements. LDL fell by 8.28 mg/dL (95% CI -11.38 to -5.18), total cholesterol by 10.82 mg/dL, triglycerides by 5.55 mg/dL and apolipoprotein B by 44.99 mg/L. Each extra 5 g a day lowered LDL by 5.57 mg/dL (95% CI -7.44 to -3.69).

Jovanovski 2018 pooled 28 trials (n = 1,924) of at least 3 weeks. About 10.2 g of psyllium a day lowered LDL by 0.33 mmol/L, non-HDL cholesterol by 0.39 mmol/L and apolipoprotein B by 0.05 g/L (all P < 0.0001). The LDL and non-HDL estimates were graded moderate quality because trials were inconsistent; apolipoprotein B was graded high.

A 2024 review of 29 trials (n = 2,769) found Plantago lowered total cholesterol by 0.28 mmol/L and LDL by 0.35 mmol/L, with no clear change in HDL or triglycerides (Zhu 2024). An older meta-analysis of 21 trials in mild-to-moderate hypercholesterolemia found a dose-response relationship and that total cholesterol fell faster than LDL (Wei 2009).

Twelve trials (n = 370, including 4 in children) found about 3 g a day of konjac glucomannan lowered LDL by 0.35 mmol/L, roughly 10%, and non-HDL by 0.32 mmol/L; 6 trials showed no effect on apolipoprotein B (Ho 2017). An older review of 14 trials (n = 531) found glucomannan lowered LDL by 15.99 mg/dL, with children and people on dietary modification benefiting less (Sood 2008).

For oat beta-glucan, Whitehead 2014 found 3 g or more a day lowered LDL by 0.25 mmol/L in 28 trials, more so when baseline LDL was higher. Yu 2022 found a 0.27 mmol/L LDL fall in 13 trials in adults with hypercholesterolemia (n = 927).

In a 12-week blinded, placebo-controlled trial of 68 patients, simvastatin 10 mg plus 15 g of psyllium a day lowered LDL by 63 mg/dL after 8 weeks, versus 55 mg/dL for simvastatin 10 mg plus placebo (P = .03). The result matched simvastatin 20 mg alone (Moreyra 2005).

The abstracts I read report blood lipids, not cardiovascular events, so it is not shown that fiber supplements prevent heart attacks or strokes. The psyllium LDL estimate carried a moderate-certainty grade because trials disagreed, and the statin add-on trial is a single, small study of one statin. The effect on LDL is also smaller than the large drops statins produce, which is why fiber is framed here as an add-on.

All treatments, including psyllium added to simvastatin, were well tolerated in the 68-patient trial (Moreyra 2005). Gas is the usual complaint: in constipation trials, flatulence was higher with fiber than with control (SMD 0.80), so building the dose gradually is sensible (van der Schoot 2022).

The sharper risk is choking. FDA labeling rules require psyllium husk health-claim foods to say they should be eaten with at least a full glass of liquid, because eating them without enough liquid may cause choking, and not by anyone with difficulty swallowing.

Fiber is not absorbed, so the concern is what it does to other medicines in the gut and to blood sugar. The studies below are small, so treat the timing advice as a sensible precaution.